Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
232,836,241
Total 13F shares
207,236,343
Share change
+2,237,018
Total reported value
$112,229,086,782
Put/Call ratio
98%
Price per share
$541.86
Number of holders
1,694
Value change
+$1,221,818,434
Number of buys
831
Number of sells
631

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
9.1%
21,231,709
$11,009,490,386 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
9%
20,920,696
$10,848,217,607 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
5%
11,720,260
$6,077,425,000 31 Mar 2024
13F
STATE STREET CORP
13F
Company
4.5%
10,479,761
$5,434,175,269 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
4,694,885
$2,427,827,157 31 Mar 2024
13F
Sanders Capital, LLC
13F
Company
1.9%
4,507,197
$2,337,161,932 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.9%
4,499,629
$2,333,237,622 31 Mar 2024
13F
FMR LLC
13F
Company
1.7%
4,053,308
$2,101,802,577 31 Mar 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.5%
3,601,675
$1,867,612,033 31 Mar 2024
13F
Capital International Investors
13F
Company
1.5%
3,498,511
$1,814,118,340 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.3%
3,000,754
$1,556,010,979 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
1.3%
2,953,844
$1,531,687,609 31 Mar 2024
13F
BAILLIE GIFFORD & CO
13F
Company
1.3%
2,914,855
$1,511,468,912 31 Mar 2024
13F
NORGES BANK
13F
Company
1.2%
2,719,804
$1,410,327,166 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
1.2%
2,695,396
$1,397,803,520 31 Mar 2024
13F
Artisan Partners Limited Partnership
13F
Company
1%
2,372,269
$1,230,116,367 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.99%
2,296,703
$1,190,932,250 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.95%
2,211,381
$1,146,689,505 31 Mar 2024
13F
Invesco Ltd.
13F
Company
0.87%
2,037,260
$1,056,400,657 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.87%
2,030,190
$1,052,553,234 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.8%
1,863,868
$966,490,084 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.79%
1,843,679
$956,020,896 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
0.78%
1,804,560
$935,734,298 31 Mar 2024
13F
First Eagle Investment Management, LLC
13F
Company
0.77%
1,782,575
$924,336,456 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.73%
1,710,144
$886,777,825 31 Mar 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.73%
1,706,870
$885,080,369 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.72%
1,669,062
$865,475,411 31 Mar 2024
13F
Brave Warrior Advisors, LLC
13F
Company
0.71%
1,645,837
$853,432,318 31 Mar 2024
13F
EAGLE CAPITAL MANAGEMENT LLC
13F
Company
0.67%
1,566,236
$812,156,015 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.67%
1,565,652
$811,853,204 31 Mar 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.66%
1,538,796
$797,927,278 31 Mar 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.64%
1,497,514
$779,456,038 31 Mar 2024
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.64%
1,500,539
$778,089,493 31 Mar 2024
13F
Amundi
13F
Individual
0.59%
1,363,482
$715,411,004 31 Mar 2024
13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC
13F
Company
0.55%
1,271,916
$659,539,323 31 Mar 2024
13F
EdgePoint Investment Group Inc.
13F
Company
0.54%
1,253,681
$650,083,746 31 Mar 2024
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
0.54%
1,247,265
$646,756,793 31 Mar 2024
13F
Newport Trust Company, LLC
13F
Company
0.51%
1,179,176
$611,449,923 31 Mar 2024
13F
Veritas Asset Management LLP
13F
Company
0.5%
1,159,979
$601,495,511 31 Mar 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.48%
1,121,612
$581,586,811 31 Mar 2024
13F
Ruane, Cunniff & Goldfarb L.P.
13F
Company
0.46%
1,074,685
$557,267,160 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.44%
1,025,088
$531,549,131 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.43%
1,001,492
$519,313,662 31 Mar 2024
13F
Orbis Allan Gray Ltd
13F
Company
0.41%
959,154
$497,359,715 31 Mar 2024
13F
Ninety One UK Ltd
13F
Company
0.39%
904,136
$468,830,682 31 Mar 2024
13F
Neuberger Berman Group LLC
13F
Company
0.38%
893,372
$463,273,678 31 Mar 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.37%
866,328
$449,062,900 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.36%
843,480
$437,378,119 31 Mar 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.36%
837,299
$434,173,097 31 Mar 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.36%
833,833
$432,275,373 31 Mar 2024
13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2024

As of 30 Jun 2024, Elevance Health, Inc. - Common Stock (ELV) was held by 1,694 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 207,236,343 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Sanders Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, AMERIPRISE FINANCIAL INC, and Capital International Investors. This page lists 1,699 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
1,653
Q2 2024 holders
1,694
Holder diff
41
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .